Oncoprotective Agent
Recent advances in cancer research have highlighted methylene blue (MB) as a promising compound for the treatment of this disease. Its therapeutic benefits in oncology are currently under active investigation.
Characteristics of Methylene Blue
MB is a specialized dye that generates and increases oxygen levels within tumors. Upon intravenous administration, it accumulates preferentially in tumor tissue, where it interacts with cancer cells characterized by high levels of a molecule called NADH.
Mechanism of Tumor Accumulation
This targeted accumulation of MB is attributed to:
- Higher metabolic rates
- Altered membrane permeability
- Overexpression of transport proteins (such as P-glycoprotein) in cancer cells
Mechanism of Action in the Tumor Microenvironment
This interaction facilitates the reduction of MB to its colorless form, leucomethylene blue, within the tumor microenvironment. In this state, it acts as a potent catalyst that helps elevate intratumoral oxygen levels.
Impact on Cancer Cells
As cancer cells thrive in low-oxygen (hypoxic) conditions, increasing oxygen availability creates a hostile environment for their survival. MB induces a shift in cellular energy production within cancer cells, from glycolysis to oxidative phosphorylation. This metabolic reprogramming renders the cancer cells more dependent on oxygen for survival.
Resultant Effect
This elevation in oxygenation levels ultimately induces selective cancer cell death.
Combination Therapy
MB demonstrates significant efficacy, particularly in combination with photodynamic therapy, as a strategy to combat various cancer types.
